If the lawsuit prevails, women across the U.S. would lose access to the most common abortion method. The FDA’s powers to approve drugs would also be weakened.
You are here: Home / The FDA’s power to approve drugs faces sweeping challenge in lawsuit seeking to pull abortion pill from U.S. market